CMA relief | Software success | Offers galore
The offers continue to come in for UK companies with one of our Stonking Small Caps on the receiving end on this occasion and another AIM-listed technology group also receiving an approach. Elsewhere, a fast-growing software group has reported impressive results, while a veterinary services business can breathe a sigh of relief on a seemingly favourable outcome to a CMA review into the sector. Read on here for our usual forthright views from the small cap world.
CVS: shares climb on favourable CMA outcomeShares in veterinary group CVS (AIM:CVSG) have climbed on news of a more favourable outcome than some had clearly anticipated to the Competition and Markets Authority (‘CMA’) review of the UK veterinary sector. The CMA’s review has come to the broad conclusion that pet owners should receive better and more transparent information on prices, treatment options, services, ownership, and other basic information. The CMA also proposes greater transparency on medicine prices and alternatives, with requirements for generic prescribing and price controls on prescriptions and interim medicines. Pet cremations came under particular scrutiny with the…